On the use of the healthy lifestyle index to investigate specific disease outcomes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 Jul 2024
Historique:
received: 24 10 2023
accepted: 03 07 2024
medline: 16 7 2024
pubmed: 16 7 2024
entrez: 15 7 2024
Statut: epublish

Résumé

The healthy lifestyle index (HLI), defined as the unweighted sum of individual lifestyle components, was used to investigate the combined role of lifestyle factors on health-related outcomes. We introduced weighted outcome-specific versions of the HLI, where individual lifestyle components were weighted according to their associations with disease outcomes. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), we examined the association between the standard and the outcome-specific HLIs and the risk of T2D, CVD, cancer, and all-cause premature mortality. Estimates of the hazard ratios (HRs), the Harrell's C-index and the population attributable fractions (PAFs) were compared. For T2D, the HR for 1-SD increase of the standard and T2D-specific HLI were 0.66 (95% CI: 0.64, 0.67) and 0.43 (0.42, 0.44), respectively, and the C-index were 0.63 (0.62, 0.64) and 0.72 (0.72, 0.73). Similar, yet less pronounced differences in HR and C-index were observed for standard and outcome-specific estimates for cancer, CVD and all-cause mortality. PAF estimates for mortality before age 80 were 57% (55%, 58%) and 33% (32%, 34%) for standard and mortality-specific HLI, respectively. The use of outcome-specific HLI could improve the assessment of the role of lifestyle factors on disease outcomes, thus enhancing the definition of public health recommendations.

Identifiants

pubmed: 39009699
doi: 10.1038/s41598-024-66772-w
pii: 10.1038/s41598-024-66772-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16330

Informations de copyright

© 2024. The Author(s).

Références

Muller, D. C. et al. Modifiable causes of premature death in middle-age in Western Europe: results from the EPIC cohort study. BMC Med. 14, 87 (2016).
doi: 10.1186/s12916-016-0630-6 pubmed: 27296932 pmcid: 4907105
Ibsen, D. B. et al. Modifiable Lifestyle recommendations and mortality in Denmark: A cohort study. Am J Prev Med. 60, 792–801 (2021).
doi: 10.1016/j.amepre.2021.01.003 pubmed: 33775511
Stampfer, M. J., Hu, F. B., Manson, J. E., Rimm, E. B. & Willett, W. C. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 343, 16–22 (2000).
doi: 10.1056/NEJM200007063430103 pubmed: 10882764
Board I of M (US) and NRC (US) NCP, Curry SJ, Byers T, Hewitt M. Lifestyle Behaviors Contributing to the Burden of Cancer [Internet]. National Academies Press (US); 2003 [cited 2019 Oct 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK223925/
Chiuve, S. E. et al. Primary prevention of stroke by healthy lifestyle. Circulation. 118, 947–954 (2008).
doi: 10.1161/CIRCULATIONAHA.108.781062 pubmed: 18697819 pmcid: 2730914
Loef, M. & Walach, H. The combined effects of healthy lifestyle behaviors on all cause mortality: A systematic review and meta-analysis. Prev Med. 55, 163–170 (2012).
doi: 10.1016/j.ypmed.2012.06.017 pubmed: 22735042
Soerjomataram, I. et al. Cancers related to lifestyle and environmental factors in France in 2015. Eur J Cancer Oxf Engl 2018(105), 103–113 (1990).
Freisling, H. et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: A multinational cohort study. BMC Med. 18, 5 (2020).
doi: 10.1186/s12916-019-1474-7 pubmed: 31918762 pmcid: 6953215
Li, Y. et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: Prospective cohort study. BMJ. 368, l6669 (2020).
doi: 10.1136/bmj.l6669 pubmed: 31915124 pmcid: 7190036
Li, Y. et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation. 138, 345–355 (2018).
doi: 10.1161/CIRCULATIONAHA.117.032047 pubmed: 29712712 pmcid: 6207481
Panagiotakos, D. B., Pitsavos, C. & Stefanadis, C. Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr. Metab. Cardiovasc. Dis. NMCD. 16, 559–568 (2006).
doi: 10.1016/j.numecd.2005.08.006 pubmed: 17126772
Buckland, G. et al. Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study. Am J Epidemiol. 170, 1518–1529 (2009).
doi: 10.1093/aje/kwp282 pubmed: 19903723
Couto, E. et al. Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br. J. Cancer. 104, 1493–1499 (2011).
doi: 10.1038/bjc.2011.106 pubmed: 21468044 pmcid: 3101925
Tindle, H. A. et al. Lifetime smoking history and risk of lung cancer: Results from the framingham heart study. J. Natl. Cancer Inst. 110, 1201–1207 (2018).
pubmed: 29788259 pmcid: 6235683
Pleasants, R. A., Rivera, M. P., Tilley, S. L. & Bhatt, S. P. Both duration and pack-years of tobacco smoking should be used for clinical practice and research. Ann. Am. Thorac. Soc. 17, 804–806 (2020).
doi: 10.1513/AnnalsATS.202002-133VP pubmed: 32348693 pmcid: 7405110
Arnold, M. et al. Cancers in France in 2015 attributable to high body mass index. Cancer Epidemiol. 52, 15–19 (2018).
doi: 10.1016/j.canep.2017.11.006 pubmed: 29161609
Hu, F. B. et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl. J. Med. 345, 790–797 (2001).
doi: 10.1056/NEJMoa010492 pubmed: 11556298
McKenzie, F. et al. Healthy lifestyle and risk of cancer in the European prospective investigation into cancer and nutrition cohort study. Medicine (Baltimore). 95, e2850 (2016).
doi: 10.1097/MD.0000000000002850 pubmed: 27100409 pmcid: 4845813
Hu, P. et al. Effect of healthy lifestyle index and lifestyle patterns on the risk of mortality: A community-based cohort study. Front Med. https://doi.org/10.3389/fmed.2022.920760 (2022).
doi: 10.3389/fmed.2022.920760 pubmed: 36536194 pmcid: 9762646
Mozaffarian, D. et al. Lifestyle risk factors and new-onset diabetes mellitus in older adults. Arch. Intern. Med. 169, 798–807 (2009).
doi: 10.1001/archinternmed.2009.21 pubmed: 19398692 pmcid: 2828342
Lv, J. et al. Adherence to a healthy lifestyle and the risk of type 2 diabetes in Chinese adults. Int. J. Epidemiol. 46, 1410–1420 (2017).
doi: 10.1093/ije/dyx074 pubmed: 28582543 pmcid: 5837408
Rajaobelina, K. et al. Population attributable fractions of the main type 2 diabetes mellitus risk factors in women: Findings from the French E3N cohort. J. Diabetes. 11, 242–253 (2019).
doi: 10.1111/1753-0407.12839 pubmed: 30098121
Aleksandrova, K. et al. Combined impact of healthy lifestyle factors on colorectal cancer: A large European cohort study. BMC Med. 12, 168 (2014).
doi: 10.1186/s12916-014-0168-4 pubmed: 25319089 pmcid: 4192278
Naudin, S. et al. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Eur. J. Epidemiol. 35, 975–986 (2020).
doi: 10.1007/s10654-019-00559-6 pubmed: 31564045
Chen, S. L. F. et al. Combined lifestyle behaviors and the incidence of common cancer types in the norwegian women and cancer study (NOWAC). Clin. Epidemiol. 13, 721–734 (2021).
doi: 10.2147/CLEP.S312864 pubmed: 34429658 pmcid: 8378914
Li, Q. et al. The associations of healthy lifestyle index with breast cancer incidence and mortality in a population-based study. Breast Cancer Tokyo Jpn. 29, 957–966 (2022).
doi: 10.1007/s12282-022-01374-w
Peila, R. et al. Healthy lifestyle index and risk of pancreatic cancer in the Women’s Health Initiative. Cancer Causes Control CCC. 33, 737–747 (2022).
doi: 10.1007/s10552-022-01558-x pubmed: 35235084 pmcid: 10286627
Meer, R., van de Pol, J., van den Brandt, P. A. & Schouten, L. J. The association of healthy lifestyle index score and the risk of renal cell cancer in the Netherlands cohort study. BMC Cancer. 23, 156 (2023).
doi: 10.1186/s12885-023-10627-6 pubmed: 36797692 pmcid: 9933336
Liu, G. et al. Adherence to a healthy lifestyle in association with microvascular complications among adults with type 2 diabetes. JAMA Netw Open. 6, e2252239 (2023).
doi: 10.1001/jamanetworkopen.2022.52239 pubmed: 36701156 pmcid: 9880795
Riboli, E. et al. European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection. Public Health Nutr. 5, 1113–1124 (2002).
doi: 10.1079/PHN2002394 pubmed: 12639222
InterAct Consortium et al. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia. 54, 2272–2282 (2011).
doi: 10.1007/s00125-011-2182-9
Danesh, J. et al. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol. 22, 129–141 (2007).
doi: 10.1007/s10654-006-9096-8 pubmed: 17295097
Ekelund, U. et al. Physical activity and gain in abdominal adiposity and body weight: prospective cohort study in 288,498 men and women. Am J Clin Nutr. 93, 826–835 (2011).
doi: 10.3945/ajcn.110.006593 pubmed: 21346093
Kuhn, M. & Johnson, K. Applied Predictive Modeling (Springer, 2013). https://doi.org/10.1007/978-1-4614-6849-3 .
doi: 10.1007/978-1-4614-6849-3
Causality, P. J. Models, reasoning, and inference 2nd edn. (Cambridge University Press, 2009).
Liao, J., Muniz-Terrera, G., Scholes, S., Hao, Y. & Chen, Y. Lifestyle index for mortality prediction using multiple ageing cohorts in the USA UK and Europe. Sci Rep. 8, 6644 (2018).
doi: 10.1038/s41598-018-24778-1 pubmed: 29703919 pmcid: 5923240
Box, G. E. P. Robustness in the Strategy of Scientific Model Building. In Robustness Stat (eds Launer, R. L. & Wilkinson, G. N.) 201–236 (Academic Press, 1979).
doi: 10.1016/B978-0-12-438150-6.50018-2
Schulze, M. B. & Hu, F. B. Epidemiology of Diabetes. In Handb Epidemiol (eds Ahrens, W. & Pigeot, I.) 1–49 (Springer, 2019).
Song, Z. et al. Association of healthy lifestyle including a healthy sleep pattern with incident type 2 diabetes mellitus among individuals with hypertension. Cardiovasc. Diabetol. 20, 239 (2021).
doi: 10.1186/s12933-021-01434-z pubmed: 34922553 pmcid: 8684653
Guasch-Ferré, M. et al. Healthy lifestyle score including sleep duration and cardiovascular disease risk. Am. J. Prev. Med. 63, 33–42 (2022).
doi: 10.1016/j.amepre.2022.01.027 pubmed: 35361505 pmcid: 9232953
Rabe, K. F., Hurst, J. R. & Suissa, S. Cardiovascular disease and COPD: Dangerous liaisons?. Eur. Respir. Rev. 27, 180057 (2018).
doi: 10.1183/16000617.0057-2018 pubmed: 30282634 pmcid: 9488649

Auteurs

Vivian Viallon (V)

International Agency for Research On Cancer (IARC-WHO), Lyon, France. viallonv@iarc.who.int.

Heinz Freisling (H)

International Agency for Research On Cancer (IARC-WHO), Lyon, France.

Komodo Matta (K)

International Agency for Research On Cancer (IARC-WHO), Lyon, France.

Anne Østergaard Nannsen (AØ)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Christina C Dahm (CC)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Anne Kirstine Eriksen (AK)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Verena A Katzke (VA)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.

Giovanna Masala (G)

Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Giovanna Tagliabue (G)

Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Vittorio Simeon (V)

Unit of Medical Statistics, University "L. Vanvitelli", Naples, Italy.

Rosario Tumino (R)

Hyblean Association for Epidemiological Research, AIRE-ONLUS, Ragusa, Italy.

Lorenzo Milani (L)

Unit of Cancer Epidemiology, Città Della Salute E Della Scienza University-Hospital, and Center for Cancer Prevention (CPO), Turin, Italy.

Jeroen W G Derksen (JWG)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Yvonne T van der Schouw (YT)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Therese Haugdahl Nøst (TH)

K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Kristin Benjaminsen Borch (KB)

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Torkjel M Sandanger (TM)

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

J Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Miguel Rodriguez-Barranco (M)

Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Catalina Bonet (C)

Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
Nutrition and Cancer Group; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Amaia Aizpurua-Atxega (A)

Sub Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, San Sebastián, Spain.
Epidemiology of Chronic and Communicable Diseases Group, Biodonostia Health Research Institute, San Sebastián, Spain.

Lluís Cirera (L)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Marcela Guevara (M)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Instituto de Salud Pública y Laboral de Navarra, 31003, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), 31008, Pamplona, Spain.

Björn Sundström (B)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Anna Winkvist (A)

Department of Public Health and Clinical Medicine, Sustainable Health, Umeå University, Umeå, Sweden.
Department of Internal Medicine and Clinical Nutrition, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Alicia K Heath (AK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Marc J Gunter (MJ)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Elisabete Weiderpass (E)

International Agency for Research On Cancer (IARC-WHO), Lyon, France.

Mattias Johansson (M)

International Agency for Research On Cancer (IARC-WHO), Lyon, France.

Pietro Ferrari (P)

International Agency for Research On Cancer (IARC-WHO), Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH